Simultaneous intra/extravascular administration of antiproliferative agents as a new strategy to inhibit restenosis: the peak of reactive cell proliferation as a hallmark for the duration of the treatment.

Authors:
Voisard R; Kucharczyk E; Deininger U; Baur R; Hombach V.

Journal:
BMC Cardiovasc Disord

Publication Year: 2002

PMCID:
PMC65511

PMID:
11825339

View on PubMed View on PMC
Journal Information

Full Title: BMC Cardiovasc Disord

Abbreviation: BMC Cardiovasc Disord

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Vascular Diseases

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
A case of endocardial dissection caused by Micra implantation.
Zhang J; Shang S; Dong Z and 8 more (2024) - Transparency Score: 3/6
A case of repeated in-stent restenosis of coronary artery as a primary manifestation of seronegativ…
Fu M; Chang S; Ma J and 1 more (2024) - Transparency Score: 3/6
A comparative trial of blood pressure monitoring in a self-care kiosk, in office, and with ambulato…
Nilsson G; Lindam A. (2024) - Transparency Score: 4/6
Activation of ETAR and ETBR in myocardial tissue characterizes heart failure induced by experimenta…
Yang P; Wu Y; Li F and 3 more (2024) - Transparency Score: 3/6
Adult-type anomalous origin of the left coronary artery from the pulmonary artery and right coronar…
Luo H; Kwaku OE; Lai Y and 1 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
0/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
COI Disclosure
Funding Disclosure
Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025